Product image of Keol-S, Aire Sintético Medicinal Acondicionado En Balas Y Bloque De Balas A 150 Y 200 Bar (Oxygen) supplied by GNH India

Keol-S, Aire Sintético Medicinal Acondicionado En Balas Y Bloque De Balas A 150 Y 200 Bar

Active Ingredient:
Oxygen
Origin:
EU

Keol-S, Aire Sintético Medicinal Acondicionado En Balas Y Bloque De Balas A 150 Y 200 Bar (Oxygen)

Oxygen, the active ingredient in Keol-S, Aire Sintético Medicinal Acondicionado En Balas Y Bloque De Balas A 150 Y 200 Bar, is a medical gas presented as a 150‑200 bar compressed gas cylinder for inhalation use. It provides supplemental oxygen to increase tissue oxygenation in patients with respiratory compromise.

GNH India supplies Keol‑S, Aire Sintético Medicinal Acondicionado En Balas Y Bloque De Balas A 150 Y 200 Bar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Air Liquide Sante International

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Keol‑S (oxygen) is used in respiratory therapy to address conditions characterized by low blood‑oxygen levels.

  • Hypoxemia: improves arterial oxygen saturation and tissue oxygen delivery.
  • Chronic obstructive pulmonary disease (COPD) exacerbations: supports breathing and reduces dyspnea.
  • Post‑operative recovery: maintains adequate oxygenation during anesthesia emergence.
  • Acute respiratory distress syndrome (ARDS): provides supplemental oxygen to sustain vital organ function.
  • High‑altitude illness: alleviates hypoxia caused by reduced atmospheric pressure.

How It Works

  • Oxygen delivered from the cylinder increases the partial pressure of inspired oxygen (FiO2), allowing greater diffusion of O2 across the alveolar membrane into the bloodstream. This raises arterial PaO2, enhances hemoglobin oxygen saturation, and improves delivery of oxygen to peripheral tissues, thereby supporting cellular metabolism in patients with compromised respiratory function.

Side Effects

Common Side Effects

  • Nasal dryness or irritation.
  • Throat discomfort.
  • Headache.
  • Dizziness.
  • Coughing.
  • Fatigue.

Serious or Rare Side Effects

  • Fire hazard when used near flammable materials.
  • Pulmonary oxygen toxicity with prolonged high‑concentration exposure.
  • Central nervous system toxicity (seizures) from hyperoxia.
  • Retinopathy of prematurity in neonates.
  • Barotrauma from improper pressure regulation.
  • Severe hypoxemia if delivery system fails.

Precautions & Warnings

Keol‑S should be used with careful clinical assessment and adherence to safety guidelines.

  • Assess baseline oxygen saturation before initiating therapy.
  • Adjust flow rate according to prescriber’s order and patient response.
  • Avoid use in patients with untreated pneumothorax.
  • Monitor for signs of oxygen toxicity during prolonged high‑flow administration.
  • Use only with compatible delivery devices and regulators.
  • Store at ambient temperature: keep cylinders upright, protect from heat and direct sunlight.

Avoid Interactions

Oxygen can interact with other agents that affect fire risk or respiratory physiology.

Major Interactions (Avoid)

  • Nitrogen oxide therapy: increased risk of methemoglobinemia.
  • Nitrous oxide anesthesia: heightened fire hazard.
  • Flammable disinfectants or solvents near the oxygen source.

Moderate Interactions (Monitor Closely)

  • Bronchodilators: may potentiate respiratory effects.
  • Systemic corticosteroids: may increase infection susceptibility.
  • Sedative agents: may depress respiratory drive when combined with high oxygen flow.

Frequently Asked Questions

Keol‑S is a medical‑grade oxygen product supplied in high‑pressure cylinders (150‑200 bar). It is used to provide supplemental oxygen to patients who need increased oxygenation, such as those with hypoxemia, COPD exacerbations, postoperative recovery, ARDS, or high‑altitude illness.

When inhaled, oxygen raises the fraction of inspired oxygen, increasing the partial pressure of oxygen in the alveoli. This enhances diffusion of O2 into the bloodstream, raising arterial PaO2 and hemoglobin saturation, which improves delivery of oxygen to tissues and supports cellular metabolism.

The dose of supplemental oxygen is individualized. A prescriber determines the flow rate (e.g., liters per minute) and duration based on the patient’s oxygen saturation, clinical condition, and therapeutic goals. Keol‑S provides the oxygen source for that prescribed regimen.

Oxygen therapy is generally considered safe in pregnancy and while breastfeeding when indicated by a healthcare professional. However, the decision to use supplemental oxygen should be made by a qualified clinician who evaluates maternal and fetal needs.

To order Keol‑S, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any required import documentation.

Keol‑S is supplied in high‑pressure cylinders (150‑200 bar), offering a compact and reliable source of medical‑grade oxygen. Compared with bulk liquid oxygen systems, cylinders provide greater portability and easier handling, while maintaining comparable purity and safety when used with appropriate regulators.

Keol‑S cylinders should be stored upright in a well‑ventilated area away from heat sources, direct sunlight, and flammable materials. Keep the cylinders secured to prevent tipping, and ensure regulators and valves are inspected regularly for leaks before each use.

Keol‑S is administered via inhalation using compatible delivery devices such as nasal cannulas, simple face masks, or non‑rebreather masks. The prescriber sets the flow rate, and the cylinder’s regulator controls the pressure to deliver the prescribed oxygen concentration.

Serious risks include fire hazards when oxygen is present near flammable substances, oxygen toxicity from prolonged high‑concentration exposure, and barotrauma if cylinder pressure is not properly regulated. Monitoring and adherence to safety protocols are essential to mitigate these risks.

Keol‑S should be avoided in patients with untreated pneumothorax, those who are receiving certain nitrous oxide or nitrogen oxide therapies, and individuals for whom supplemental oxygen is contraindicated by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Oxygen

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT